Basic info
Industry
biotechnology research
Sectors
autoimmune diseases
Biotechnology
sarcoma
Cytokines
Late-stage prostate cancer
Septic shock
Oncology
antisense oligonucleotides (ASOs)
Pharmaceutical
RNA therapeutics
lupus
Cytokine storm
Interferon signaling pathway
COVID-19
Health Care
low-dose radiotherapy
psoriasis
Converting Cold to Hot tumors
cancer
Therapeutic opportunities of isoflavonoid compounds
chronic inflammation
STING antagonist
Date founded
2015
Funding rounds raised
Total raised
$18M
from 1 investors over 1 rounds
N
Noxopharm Limited raised $18M on July 29, 2019
Investors: The Lind Partners, LLC